Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease Trial Phase 3 Terminated Sept. 24, 2017
Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease Trial N/A Completed Sept. 24, 2017
A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging Trial Phase 2 Terminated Sept. 17, 2017
Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients Trial Phase 3 Terminated Sept. 17, 2017
Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease Trial Phase 4 Completed Sept. 14, 2017
A Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease Patient Trial Phase 2 Unknown Sept. 13, 2017
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes Trial Phase 3 Withdrawn Sept. 12, 2017
Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia Trial N/A Completed Sept. 11, 2017
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation Trial N/A Completed Sept. 6, 2017
Evaluating the Influence of Externally vs. Internally Focused Exercise on Rehabilitation in Parkinson's Disease Trial N/A Completed Aug. 30, 2017
Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy Trial N/A Terminated Aug. 27, 2017
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067 Trial Phase 1 Completed Aug. 23, 2017
Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease Trial Phase 4 Unknown Aug. 22, 2017
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's Trial Phase 3 Completed Aug. 21, 2017
Deep Brain Stimulation for Parkinson's Disease: the Globus Pallidus Internus Versus Subthalamic Nucleus Trial N/A Unknown Aug. 16, 2017
The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease Trial Phase 1 Completed Aug. 13, 2017